| Absorption |
| Blood-Brain Barrier | BBB+ | 0.7225 |
| Human Intestinal Absorption | HIA+ | 0.8992 |
| Caco-2 Permeability | Caco2+ | 0.5589 |
| P-glycoprotein Substrate | Substrate | 0.7150 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8482 |
| Non-inhibitor | 0.8708 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7235 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7549 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7633 |
| CYP450 2D6 Substrate | Non-substrate | 0.8769 |
| CYP450 3A4 Substrate | Substrate | 0.5819 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7003 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8532 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9398 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8745 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8180 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8486 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8995 |
| Non-inhibitor | 0.8646 |
| AMES Toxicity | Non AMES toxic | 0.9200 |
| Carcinogens | Non-carcinogens | 0.9523 |
| Fish Toxicity | High FHMT | 0.9974 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.5114 |
| Honey Bee Toxicity | High HBT | 0.8204 |
| Biodegradation | Not ready biodegradable | 0.9946 |
| Acute Oral Toxicity | IV | 0.4123 |
| Carcinogenicity (Three-class) | Non-required | 0.4329 |